- Global Pharma News & Resources

PAION AG raises EBITDA forecast for fiscal year 2022

PAION AG / Key word(s): Change in Forecast
PAION AG raises EBITDA forecast for fiscal year 2022

15-Nov-2022 / 16:28 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Ad-hoc announcement pursuant to Art. 17 of the EU Market Abuse Regulation (MAR)

PAION AG raises EBITDA forecast for fiscal year 2022

Aachen (Germany), 15 November 2022 – PAION AG (ISIN: DE000A0B65S3 / WKN A0B65S) announces that, based on the results for the first nine months of 2022, it is raising the outlook for the full year 2022 published with the Annual Report 2021. In contrast to the previously forecast negative EBITDA (EUR -9.0 million to EUR -2.5 million), PAION AG now expects EBITDA for the fiscal year 2022 to be in the corridor of EUR -1.5 million to EUR +0.5 million.

PAION AG will publish the figures for the third quarter of 2022 and the nine-month figures 2022 on
16 November 2022 as part of the consolidated quarterly statement for the first nine months of 2022.

PAION AG, Aachen

PAION contact:

Investor Relations
cometis AG
Thorben Burbach
Tel.: +49 (0) 611 205855 23


15-Nov-2022 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

Language: English
Company: PAION AG
Heussstraße 25
52078 Aachen
Phone: +49 (0)241-4453-0
Fax: +49 (0)241-4453-100
ISIN: DE000A0B65S3
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1488519

End of Announcement EQS News Service

Editor Details

Last Updated: 15-Nov-2022